GHISLAINE MAXWELL ACCT. For the Period 1/1/14 to 1/31/14 Account Summary Asset Allocation Beginning Ending Change Estimated Current Asset Allocation Market Value Market Value In Value Annual Income Allocation Equity Alternative Assets 1,133,131.88 1,117,026.41 (18,105.25) 50,043.72 22% 1% 57,278.79 59,229.07 1,962.28 Cash 8 Fixed Income 3,898,180.31 3,897,134.07 (1,028.24) 21,151.37 74% Other 162,555.11 162,777.00 221.89 3% Market Value Accruals $6,261,123.87 $6,236,166.66 ($14,867.32) 8,152.08 10,191.15 2,039.07 571.195.09 100% Market Value with Accruals 66,269,276.96 66,248,367.70 ($12,918.26) Portfolio Activity Current Year-to-Date Period Value Value Beginning Market Value 6,261,123.87 6,261,123.87 Wthdrawals 8 Fees Securities Transferred In Securities Transferred Out (229.45) (229.45) 1.237.066 20 1,237,066.20 (1.236.836.75) (1,238,838.75) Net Contributions/Withdrawals Income 8 Distributions Change In Investment Value $0.00 $0.00 9.108.89 9,108.89 (24,066.21) (24.066.21) Ending Market Value Accruals $6,236,166.56 $6,236,166.66 10,191 15 10,191.15 Market Value with Accruals $6,246,367.70 $6,246,367.70 JP Morgan 0 int, Alf *maw. AsserS &nary Cash& Find ream. Page 2 of 30 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00049391 SDNY_GM_00318589 EFTA01521940